Aspira Women's Health enters $10M equity line with Lincoln Park Capital

Aspira Women's Health Inc.

Lincoln Park committed to purchase up to $10M of Aspira common stock at company's discretion over 24 months.
Purchase price set at 95% of the lower of same-day lowest sale price or average of three lowest closing prices over prior 10 days.
Regular purchases: up to 50k-100k shares/day, capped at $500k per purchase; accelerated purchases allowed.
Commitment shares issued: 3% of $10M commitment ($300k worth) as consideration to Lincoln Park.
Company may terminate agreement at any time with one business day notice; Lincoln Park prohibited from short selling.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Aspira Women's Health Inc. entered into Purchase Agreement with Lincoln Park Capital Fund, LLC valued at $10.0 million (effective 2025-12-23).

Action: entry
Agreement: equity purchase
Counterparty: Lincoln Park Capital Fund, LLC
Value: $10.0 million
Effective: 2025-12-23

Exact text from the filing

On December 23, 2025, Aspira Women’s Health Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with Lincoln Park Capital Fund, LLC (“Lincoln Park”), pursuant to which Lincoln Park committed to purchase, at the Company’s direction from time to time, up to an aggregate of $10.0 million of the Company’s common stock

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-124245

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.